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Abstract
The literature concerning the use of goal directed haemodynamic
therapy (GDHT) in high risk surgical patients has been importantly
increased by the study of Lopes and colleagues. Using a minimally
invasive assessment of fluid status and pulse pressure variation
monitoring during mechanical ventilation, improvements were seen
in post-operative complications, duration of mechanical ventilation,
and length of hospital and intensive care unit (ICU) stay. Many
small studies have shown improved outcome using various GDHT
techniques but widespread implementation has not occurred.
Those caring for perioperative patients need to accept the
published evidence base or undertake a larger, multi-centre study.
In this issue, Lopes and colleagues [1] add to the list of
studies investigating the concept of goal directed
haemodynamic therapy (GDHT). GDHT in high risk surgical
patients has been investigated for over 20 years [2]. A variety
of strategies and monitoring modalities have been applied
and in general have resulted in improved patient outcomes
[3]. We have worked through pulmonary artery catheters,
Doppler probes, and less invasive methods of cardiac output
measurement, but the recent paper is the first to use a truly
minimally invasive technique to assess the requirement for
further fluid infusions above normal perioperative care. In their
study of goal directed fluid management based on pulse
pressure variation monitoring during high risk surgery, they
demonstrate a spectacular improvement in outcome using
their monitoring and fluid management strategy. Pulse
pressure variation in mechanically ventilated patients has
been shown to be a good predictor of fluid responsiveness
and by targeting this parameter Lopes and colleagues
increased the mean volume of intra-operative fluid infused
from 1,694 ml in the control arm to 4,618 ml in the treatment
arm. Despite comparable pre-operative demographics,
improvements were seen in post-operative complication
rates, duration of mechanical ventilation and length of hospital
and intensive care unit (ICU) stay. It is the dramatic outcome
improvement that will be the talking point in this study and
questions will be raised about the nature of treatment given
to the control group – were they undertreated, what
protocols were used for them and is this baseline mortality
comparable to experience in my institution? On this last point
it is noteworthy that other studies from South America have
shown similar control outcomes [4].
Despite the quantity of evidence in support of the principle of
GDHT, implementation has been patchy. There are a number
of reasons for this including a lack of familiarity with
preventative medicine in the perioperative setting, confusing
terminology, problems with identifying patients who might
benefit, doubts about the evidence, little peer pressure to
undertake such protocols, a confusion with the debate on
efficacy of pulmonary artery catheterisation and the use of
GDHT in the situation of sepsis, and implementation issues
such as requirement for investment, identifying suitable
clinical areas and personnel.
On these last points the current study may be very influential
as the advantage of the approach used by Lopes and
colleagues is that the technique is simple and requires very
little extra investment.
However, another reason for the slow uptake of this concept
is that the evidence for GDHT loses some of its strength
when closely examined. The meta-analysis by Poeze and
colleagues [5] demonstrated that small, ‘poor quality’ studies
generally produce much larger treatment effects than bigger,
higher quality studies. In this meta-analysis there was only
one trial with a smaller sample size than the trial by Lopes and
colleagues, and when only higher quality trials were included
in the analysis there was no statistically significant
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improvement in outcome from GDHT. One reason that the
study was so small is that it was stopped early because
marked clinical benefit was observed. While one can
sympathize with the trialists’ desire to move as soon as
possible to treatment that they observe improving patient
outcome, the practice of stopping trials early due to benefit
has been seriously questioned. In the analysis by Montori and
colleagues this practice has been shown to result in
exaggerated treatment effects [6].
It is unusual in medical care to have proposed a relatively
simple treatment that has received considerable positive
support from randomised clinical trials over a number of
years, in different clinical settings; and in economic analyses
has proved to be cost effective; which has not been adopted.
Parallels can be seen in the failure of widespread adoption of
selective decontamination of the digestive tract [7]. It seems
unlikely that further small trials will result in the breakthrough
to widespread implementation that the evidence seems to
warrant and it seems quite clear that what is required is a
large, multicentre, randomised trial of a GDHT in high risk
surgical patients. If the strategy suggested by Shoemaker
and investigated now by Lopes and colleagues and resulting
in 20 or so original trials in the intervening period [8]
continues to deliver the observed reductions in complications
and length of stay in a larger trial setting then it may truly
revolutionise perioperative care for all patients.
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